It’s taken LVMH nearly a year-and-a-half to regain its spot as Europe’s biggest stock from Novo Nordisk A/S.Most Read from ...

The US plans to slash the price it pays for the Novo Nordisk A/S blockbusters Ozempic and Wegovy ... Other drugs up for 2027 ...

Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.

Viking Therapeutics investors face challenges as stock plummets, cash runway helps but betting on early stage biopharma ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Brii said it agreed to purchase the assets from VBI Vaccines Inc. and its creditors for $18 million. The deal gives Brii full access to the remaining IP, patents and materials related to BRII-179, an ...

BMI OrganBank has secured a $3.5 million federal grant that will help the Winston-Salem company advance its kidney preservation technology and prepare for clinical trials.

McKesson's stock appears undervalued, trading at 18 times forward earnings and free cash flow. See why MCK is a Hold.

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...

Ozempic belongs to a class of drugs known as GLP-1 receptor agonists and has the same active ingredient as the company's ...